Clinical Trials Sponsored by Inspirata Europe Ltd.

Total 134 results

Inspirata Europe Ltd.

Completed

Concordance Between Omnyx System With Omnyx .RTS Images and the Omnyx Dynamyx Software With Hamamatsu .NDPI Images

Diagnoses Disease

United Kingdom
Inspira Medical AB
NasVax Ltd

Unknown

Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

Chronic Hepatitis C

Austria, Poland
Cardiovalve Ltd.
Meditrial Europe Ltd.

Recruiting

Cardiovalve Transfemoral System - FIM Study

Mitral Regurgitation

Lithuania
Otsuka Pharmaceutical Europe Ltd

Unknown

A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe (ACQUIRE)

Autosomal Dominant Polycystic Kidney Disease

Spain, United Kingdom, Germany, France, Belgium, Switzerland, Austria
Otsuka Pharmaceutical Europe Ltd

Completed

Adacolumn in Refractory UC Patients Trial (ART)

Ulcerative Colitis, Active Moderate

France
Otsuka Pharmaceutical Europe Ltd

Completed

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain (PROSIGO)

Schizophrenia

Spain
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain (ALGA)

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Spain
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy (ASSERT)

Cancer | Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Italy
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH (SAMPLE)

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Germany, Spain
Otsuka Pharmaceutical Europe Ltd

Completed

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy (DOMINO)

Schizophrenia

Italy
Beta-Stim Ltd.
Meditrial Europe Ltd.

Completed

Balance System Study in Type 2 Diabetic Patients

Obesity | Type 2 Diabetes

Germany
Chugai Pharma Europe Ltd.

Completed

Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

Solid Tumors

United Kingdom
Transseptal Solutions Ltd.
Meditrial Europe Ltd.

Completed

Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation

Atrial Fibrillation

France, Germany
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Cre8™ BTK Post Market Clinical Follow-up Study

Peripheral Arterial Disease

Italy
AorticLab Srl
Meditrial Europe Ltd.

Completed

NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device (NAUTILUS)

Aortic Valve Stenosis | Intracranial Embolism and Thrombosis

Italy, Belgium
CoreMedic GmbH
Meditrial Europe Ltd.

Active, not recruiting

ChordArt System for Mitral Regurgitation (CHAGALL)

Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Repair

Lithuania
LifeScan
Bio-Kinetic Europe, Ltd.

Completed

Project BLOOM Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation

Diabetes Mellitus

United Kingdom
Cardiovalve Ltd.
Meditrial Europe Ltd.; Meditrial SrL

Recruiting

AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System (AHEAD)

Mitral Regurgitation | Mitral Valve Disease

Germany, Italy, Greece
Odin Medical
Meditrial Europe Ltd.

Recruiting

EAGLE Trial CADDIE Artificial Intelligence Endoscopy (EAGLE)

Colorectal Cancer | Polyp of Colon | Adenoma Colon

Germany, Georgia, Italy, Poland, Spain, United Kingdom
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Inperia Advance Post-Market Retrospective Study

Peripheral Arterial Disease

France
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Isthmus Logic Post Market Clinical Follow-up Study

Peripheral Arterial Disease

Italy
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The EasyFlype/EasyHiFlype Post Market Clinical Follow-up Study.

Peripheral Arterial Occlusive Disease | Peripheral Artery Disease

Italy
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

RADIX 2 RENAL STENT Post-Market Retrospective Study (RADIX 2)

Renal Failure | Renal Artery Stenosis

Italy
Claret Medical
Meditrial Europe Ltd.

Completed

Carotid Filtration During Endovascular Aortic Valve Implantation

Heart Diseases
Dainippon Sumitomo Pharma Europe LTd.

Terminated

Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114

Rheumatoid Arthritis (RA)

Czech Republic, Germany, Poland, United Kingdom, Hungary, Netherlands
LifeScan
Bio-Kinetic Europe, Ltd.

Completed

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

Diabetes Mellitus

United Kingdom
Future Cardia, Inc
Meditrial Europe Ltd.

Recruiting

Future Cardia™ Insertable Cardiac Monitor in Subjects With Paroxysmal Atrial Fibrillation (First-in-Human Study)

Atrial Fibrillation | Arrhythmias, Cardiac | Bradycardia | Ventricular Tachycardia | Asystole

Croatia
Innovative Cardiovascular Solutions
Meditrial Europe Ltd.

Completed

European Study Evaluating the EMBLOK Embolic Protection System During TAVR

Aortic Valve Disease

Italy
Morphotek
Eisai Europe Ltd. (United Kingdom)

Terminated

Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse

Ovarian Cancer

United States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Screening for Advanced Heart Failure Treatment (SEE-HF) (SEE-HF)

Advanced Heart Failure | CRT and/or ICD

Netherlands, Sweden, Denmark, France, Germany, United Kingdom
iOMEDICO AG
Chugai Pharma Europe Ltd.

Completed

Patient Reported Outcomes Registry in Patient With Cancer Cachexia (PROXie)

Metastatic Pancreatic Cancer | NSCLC, Metastatic

Germany
Rennes University Hospital
Thoratec Europe Ltd

Withdrawn

LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization (CHECKMATE)

Heart Failure at NYHA Stage III or IV | Non Responders to Resynchronization | Non Candidates for Transplantation

France, Germany
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE) (TRACE)

Anticoagulation | Left Ventricular Assist Device

United States, Austria, France, Germany, Czechia
Maruho Europe Limited
Maruho Co., Ltd.

Completed

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Plaque Psoriasis

Germany, Austria, Bulgaria, Hungary, Lithuania, Poland
Glenmark Pharmaceuticals Europe Ltd. (R&D)

Unknown

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Asthma

India
Glenmark Pharmaceuticals Europe Ltd. (R&D)

Unknown

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

India
Astellas Pharma Europe Ltd.

Completed

Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients (CHORUS)

Kidney Transplantation

Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Poland, Portugal, Romania, Serbia, Spain, Taiwan, Thailand, United Kingdom, Vietna...
Astellas Pharma Europe Ltd.

Completed

Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on Dialysis

Chronic Kidney Disease (CKD)

Sweden
Hoffmann-La Roche
Chugai Pharma Europe Ltd.

Completed

Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice (ARATA)

Rheumatoid Arthritis

Germany
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment (ELEVATE)

Non-diabetic Painful Peripheral Polyneuropathy | Postherpetic Neuralgia (PHN) | Peripheral Nerve Injury (PNI)

Armenia, Austria, Belarus, Belgium, Bulgaria, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Turkey, United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (BEYOND)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases

Greece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
Astellas Pharma Europe Ltd.

Terminated

To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks

Validation | Dried Blood Spot | Transplant Patients

France, United Kingdom
Astellas Pharma Europe Ltd.

Completed

Observation of the Use of QUTENZA™ in Standard Clinical Practice (ASCEND)

Peripheral Neuropathic Pain

Austria, Greece, Italy, Portugal, Spain, Switzerland, United Kingdom
Astellas Pharma Europe Ltd.

Completed

Vesitirim™ in Men Postmarketing Observational Study (VIM)

Overactive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)

Ireland
Plethora Solutions Ltd
Bio-Kinetic Europe, Ltd.; Omnicare Clinical Research

Completed

A Safety and Tolerability Study of Administration of PSD502

Premature Ejaculation

United Kingdom
Astellas Pharma Europe Ltd.

Active, not recruiting

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Liver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine Transplantation

Belgium, Czechia, France, Germany, Italy, Poland, United Kingdom
Astellas Pharma Europe Ltd.

Completed

A Survey About Trade-offs When Choosing Menopause Treatments

Moderate to Severe Vasomotor Symptoms

United Kingdom
Merit Medical Systems, Inc.
Meditrial Europe Ltd.

Completed

Evaluation of the Surfacer System Approach to Central Venous Access (SAVEUS)

Venous Occlusion

United States
Astellas Pharma Europe Ltd.

Completed

A Survey About Hot Flashes in Women Going Through the Menopause

Vasomotor Symptoms | Menopause

United Kingdom

Clinical Trials Sponsored by Inspirata Europe Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations